Explore more publications!
Everything Worth Reading
Got News to Share?

Press Releases

Disc Medicine Receives Complete Response Letter from FDA for Bitopertin for the Treatment of EPP
Feb. 13, 2026

Disc Medicine Receives Complete Response Letter from FDA for Bitopertin for the Treatment of EPP

Indeterminate GlobeNewswire, Inc.
Zemill Headlines 'A Snazzy Sneakers & PoJazz Affair' Scholarship Fundraising Concert on March 28 in Dallas
Feb. 9, 2026

Zemill Headlines 'A Snazzy Sneakers & PoJazz Affair' Scholarship Fundraising Concert on March 28 in Dallas

Neutral EIN Presswire
Medicenna Announces Changes to Board Composition
Feb. 13, 2026

Medicenna Announces Changes to Board Composition

Indeterminate GlobeNewswire, Inc.
Fifteen-Year-Old Clarisa Faces A Challenge of Life and Faith and Finds Strength
Feb. 11, 2026

Fifteen-Year-Old Clarisa Faces A Challenge of Life and Faith and Finds Strength

Indeterminate GlobeNewswire, Inc.
Beyond Air® Reports Fiscal Third Quarter 2026 Financial Results and Provides Corporate Update
Feb. 13, 2026

Beyond Air® Reports Fiscal Third Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire, Inc.
Netramark Announces Uplisting to Toronto Stock Exchange
Feb. 13, 2026

Netramark Announces Uplisting to Toronto Stock Exchange

Indeterminate GlobeNewswire, Inc.
Global Conjugate Vaccine Market to Reach USD 21.77 Billion by 2030 | MarketsandMarkets™
Feb. 13, 2026

Global Conjugate Vaccine Market to Reach USD 21.77 Billion by 2030 | MarketsandMarkets™

Indeterminate GlobeNewswire, Inc.
Iterum Therapeutics Provides Business Update
Feb. 13, 2026

Iterum Therapeutics Provides Business Update

Indeterminate GlobeNewswire, Inc.
Echoes of the Timeless Wins 2026 Independent Press Award for Visionary Fiction
Feb. 5, 2026

Echoes of the Timeless Wins 2026 Independent Press Award for Visionary Fiction

Neutral EIN Presswire
Decoding Our DNA: The Human Impact Behind SNP Genotyping’s USD 19.48 Billion Growth by 2034
Feb. 13, 2026

Decoding Our DNA: The Human Impact Behind SNP Genotyping’s USD 19.48 Billion Growth by 2034

Indeterminate GlobeNewswire, Inc.
Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2026
Feb. 12, 2026

Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2026

Indeterminate GlobeNewswire, Inc.
Minivela Entertainment News: Wuthering Heights Comes to Theaters This Weekend and Gave Birth to the Telenovela
Feb. 13, 2026

Minivela Entertainment News: Wuthering Heights Comes to Theaters This Weekend and Gave Birth to the Telenovela

Indeterminate GlobeNewswire, Inc.
Medicus Pharma Receives FDA “Study May Proceed” Clearance For Teverelix® Phase 2b Study in Advanced Prostate Cancer Patients with High Cardiovascular Risk
Feb. 10, 2026

Medicus Pharma Receives FDA “Study May Proceed” Clearance For Teverelix® Phase 2b Study in Advanced Prostate Cancer Patients with High Cardiovascular Risk

Indeterminate GlobeNewswire, Inc.
Galecto Announces Pricing of $275 Million Underwritten Public Offering
Feb. 11, 2026

Galecto Announces Pricing of $275 Million Underwritten Public Offering

Indeterminate GlobeNewswire, Inc.
Make it a great day or not, the choice is yours for Clarisa's journey through challenges and choices in Houston’s Near Northside barrio.
Feb. 10, 2026

Make it a great day or not, the choice is yours for Clarisa's journey through challenges and choices in Houston’s Near Northside barrio.

Indeterminate GlobeNewswire, Inc.
[Latest] Global Large And Small Scale Bioprocessing Market Size/Share Worth USD 277.4 Billion by 2035 at a 11.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Growth Rate, Value, SWOT Analysis)
Feb. 10, 2026

[Latest] Global Large And Small Scale Bioprocessing Market Size/Share Worth USD 277.4 Billion by 2035 at a 11.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Growth Rate, Value, SWOT Analysis)

Indeterminate GlobeNewswire, Inc.
Ultragenyx Reports Fourth Quarter and Full Year 2025 Financial Results and Corporate Update
Feb. 12, 2026

Ultragenyx Reports Fourth Quarter and Full Year 2025 Financial Results and Corporate Update

Indeterminate GlobeNewswire, Inc.
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
Feb. 12, 2026

CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results

Indeterminate GlobeNewswire, Inc.
Galecto Announces Proposed Underwritten Public Offering of Common Stock and Preferred Stock
Feb. 10, 2026

Galecto Announces Proposed Underwritten Public Offering of Common Stock and Preferred Stock

Indeterminate GlobeNewswire, Inc.
Psychological Thriller Explores the Terrifying Power of Manipulation, Denial, and Family Loyalty
Feb. 4, 2026

Psychological Thriller Explores the Terrifying Power of Manipulation, Denial, and Family Loyalty

Neutral EIN Presswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions